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Piceatannol is a stilbenoid, a metabolite of resveratrol found in red wine. Piceatannol and sera from rats orally given piceatannol
were found to dose-dependently suppress both the proliferation and invasion of AH109A hepatoma cells in culture. Its anti-
proliferative eﬀect was based on cell cycle arrest at lower concentration (25∼50μM) and on apoptosis induction at higher con-
centration (100μM). Piceatannol suppressed reactive oxygen species-potentiated invasive capacity by scavenging the intracellular
reactive oxygen species. These results suggest that piceatannol, unlike resveratrol, has a potential to suppress the hepatoma
proliferationbyinducingcellcyclearrestandapoptosisinduction.Theyalsosuggestthattheantioxidativepropertyofpiceatannol,
like resveratrol, may be involved in its anti-invasive action. Subsequently, piceatannol was found to suppress the growth of solid
tumor and metastasis in hepatoma-bearing rats. Thus, piceatannol may be a useful anticancer natural product.
1.Introduction
Cancer cells have two biological properties, that is, endless
proliferation and metastasis. Invasion is a most important
and characteristic step in the complicated process of cancer
cells [1]. The blockage of these biological events by drugs or
factors from food and natural resources will prolong the
life span of an aﬀected host. Our previous research showed
that green, oolong, and black tea extracts, the sera from rats
orally given these teas, and related components inhibited
the proliferation and invasion of a rat ascites hepatoma cell
line of AH109A [2] through induction of apoptosis and cell
cycle arrest [3] and antioxidative activity [4]. Lignans also
suppressed both the proliferation and invasion of AH109A
hepatoma cells in vitro, and hence solid tumor growth
and metastasis of AH109A cells in vivo [5]. Resveratrol
(3,5,4 -trihydroxy-trans-stilbene) is known to possess cancer
chemopreventive activity and strong antioxidative activity
[6]. Hsieh et al. reported that resveratrol showed a greater
antiproliferative eﬀect on highly invasive breast carcinoma
cells (MDA-MB-435) than on minimally invasive cells
(MCF-7) [7]. However, our previous study showed that, in
the hepatoma cells, resveratrol as such showed a weaker sup-
pressive eﬀect on the proliferation than on the invasion, and
the sera from rats orally given resveratrol completely lost the
antiproliferative activity in culture, although its anti-invasive
activitywasmaintained[8,9].Theseﬁndingssuggestthatthe
eﬀectofresveratrolontheproliferationmaybedependenton
cancer cell properties. Piceatannol (3,4,3 ,5 -tetrahydroxy-
trans-stilbene), an analogue of resveratrol, has been reported
to induce apoptosis and cell cycle arrest in human melanoma
cell (SK-Mel-28) [10].
In the present study, we examined whether piceatannol
or its in vivo metabolite(s) would have antiproliferative and
anti-invasive eﬀects against AH109A and their modes of
actions.
2.MaterialsandMethods
2.1. Materials. Piceatannol was purchased from Sigma Che-
mical Co. (St. Louis, MO, USA). It was resolved in absolute
ethanol(WakoPureChemicalIndustries,Ltd.,Osaka,Japan)2 Journal of Biomedicine and Biotechnology
and the piceatannol solution was added to the medium at a
ﬁnal ethanol concentration of 0.2%. Control medium con-
tained 0.2% ethanol alone. All other reagents were of the best
grade commercially available.
2.2. Culture of AH109A Hepatoma Cells. The animal exper-
iments in this article were conducted in accordance with
guidelines established by the Animal Care and Use Commit-
tee of Tokyo University of Agriculture and Technology and
wereapprovedbythiscommittee.MaleDonryurats(4weeks
of age) were purchased from NRC Haruna (Gunma, Japan).
AH109A cells were generously provided by the Cell Resource
Center for Biomedical Research, Tohoku University, Sendai,
Japan. AH109A cells were maintained in peritoneal cavity of
male Donryu rats and isolated from accumulated ascites and
then cultured in Eagle’s minimum essential medium (MEM)
(Nissui Pharmaceutical Co., Tokyo, Japan) containing 10%
calf serum (CS, JRH Biosciences, Lenaxa, KS, USA) (10%
CS/MEM). These cells were cultured for at least 2 weeks
after isolation to eliminate contaminated macrophages and
neutrophils and used for the assays described hereinafter.
2.3. In Vitro Proliferation and Invasion Assays. Eﬀect of pi-
ceatannol on AH109A proliferation was examined by meas-
uring the incorporation of [methyl-3H]thymidine (0.15μCi/
well, speciﬁc radioactivity; 20Ci/mmoL, PerkinElmer Life
and Analytical Sciences, Boston, MA, USA) into DNA as de-
scribed previously [8, 11]. Eﬀect of piceatannol on AH109A
invasion was estimated by coculturing AH109A cells with
rat mesentery-derived mesothelial cell (M-cell) monolayers,
which were isolated and cultured from Donryu rats as
described previously [12] with slight modiﬁcations [13].
Brieﬂy, mesothelial cells (M-cells) were isolated from mesen-
tery of male Donryu rats (6–8 weeks of age). After digestion
by trypsin, 1.3–2.0 × 105 M-cells were plated in a 60 mm
culture dish with 2 mm grids (Corning Incorporated,
Corning, NY, USA) and cultured for 5–7 days to attain a
conﬂuent state in 10% CS/MEM. Then, AH109A cells (2.4 ×
105 cells per dish) were applied on the monolayer of M-
cells in 10% CS/MEM with piceatannol for 24h. Invaded
cells and colonies underneath M-cells were counted with a
phase-contrast microscope. The invasive activity of AH109A
cells was expressed as the number of invaded cells and
colonies/cm2.
2.4. Ex Vivo Assay. Ex vivo assay was performed with picea-
tannol-loaded rat sera (RS). Piceatannol was suspended in
a 0.3% carboxymethyl cellulose sodium salt (CMC, Wako
Pure Chemical Industries, Osaka, Japan) aqueous solution at
concentrations of 0.25, 0.5, and 1mg/mL, unless otherwise
noted. Piceatannol suspension or 0.3% CMC alone (vehicle
control) (1mL/100g body weight) was intubated to male
Donryu rats (5 weeks old) which had been fasted overnight,
and blood was collected 2h after oral administration as
described previously [8, 13]. Blood from rats given vehicle
alone was also collected. The sera were prepared by cen-
trifugation, sterilized by ﬁltration, and added to the culture
medium at a concentration of 10% instead of CS.
2.5.FlowcytometricAnalysesofCellCyclePhasesandAnnexin-
V-FITC Staining of Apoptotic Cells. For cell cycle analysis,
3.0 × 105 cells of AH109A per well were seeded in a 6-well
plate in the medium containing various concentrations of
piceatannol and cultured for 24h. Cells were collected and
washed twice with sterilized, Ca2+-a n dM g 2+-free, phos-
phate-buﬀered saline [PBS(−)]. Thereafter, 500μLo fp r o -
pidium iodide (PI) solution containing 1mg of PI (Sigma
Chemical Co., St. Louis, MO, USA) in 20mL of 1% Triton
X-100 (Sigma) and 0.1% of sodium citrate (Wako Pure
Chemical Industries Ltd., Osaka, Japan) was added and cells
were incubated for 30min on ice. Cells at diﬀerent cell cycle
phases were then analyzed with a ﬂow cytometer (EPICS
ELITE EPS, Beckman-Coulter, Hialeah, FL, USA) as previ-
ously described [3]. The eﬀect of piceatannol on apoptosis
in AH109A cells was assessed using Annexin-V-FITC kit
(IMMUNOTECH, Marseille, France) according to the man-
ufacturer’s instructions. Phosphatidylserine (PS), which can
speciﬁcally bind to Annexin-V, is one of the phospholipids
in the cell membrane and exists predominantly in inner
leaﬂet of the cell membrane of normal cells. When apoptosis
occurs, PS in the cell membrane immediately appears on the
outer leaﬂet of the cell membrane. The cells with PS on their
surfacecanthusbethoughttobeearlyapoptoticcells.Brieﬂy,
5×105 cells of AH109A per well were seeded in a 6-well plate
and cultured in the medium containing 0, 50, and 100μM
piceatannol for 3h. At the end of culture, cells were labeled
with Annexin-V-FITC and analyzed with a ﬂow cytometer as
described previously [14].
2.6. Pretreatment of AH109A Cells with Hydrogen Peroxide.
AH109Acellswereculturedfor4hintheabsenceorpresence
of 10μM piceatannol with or without 25μMh y d r o g e np e r -
oxide (H2O2, Wako Pure Chemical Industries). Hydrogen
peroxide was employed as exogenous reactive oxygen species
(ROS). AH109A cells were then washed once with 10% CS/
MEM and seeded on the M-cell monolayer in 10% CS/MEM
without piceatannol and ROS. After cultured for 24h, in-
vaded cells and colonies underneath M-cells were counted
with a phase-contrast microscope as described previously.
2.7. Flowcytometric Analysis of Intracellular Peroxide in
AH109A Cells. Intracellular peroxide levels in AH109A cells
were assessed by ﬂow cytometric analysis using a ﬂuoro-
metric probe (2 ,7 -dichloroﬂuorescin diacetate; DCFH-DA,
Molecular Probes, Eugene, OR) [15]w i t haﬂ o wc y t o m e t e r
as described previously [16].
2.8. In Vivo Eﬀect of Piceatannol on Soild Tumor Growth
and Metastasis. Male Donryu rats (3 weeks of age) were
maintained on a stock pellet diet (CE-2, CLEA Japan, Tokyo,
Japan)for10days.Starting4dayspriortoAH109Acellinjec-
tions, the rats were fed AIN-93G basal diet containing 20%
casein (Oriental Yeast Co., Ltd., Tokyo, Japan), 39.75% β-
corn starch (Nihon Nosan Kogyo Co. Ltd., Yokohama,
Japan), 13.2% α-corn starch (Nihon Nosan Kogyo Co. Ltd.),
10% sucrose (Nihon Nosan Kogyo Co. Ltd.), 7% corn oil
(Miyazawa Yakuhin Co. Ltd., Tokyo, Japan), 5% cellulose
powder (Oriental Yeast Co., Ltd.), 3.5% mineral mixtureJournal of Biomedicine and Biotechnology 3
(AIN-93G composition, Nihon Nosan Kogyo Co. Ltd.), 1%
vitamin mixture (AIN-93 composition, Nihon Nosan Kogyo
Co. Ltd.), 0.3% L-cystine (Wako Pure Chemical Industries,
Ltd.), and 0.25% choline bitartrate (Wako Pure Chemical
Industries, Ltd.). Piceatannnol was given to rats by adding
0.001% and 0.005% to the basal diet at the expense of β-corn
starch. Each rat was implanted subcutaneously on one site
in the dorsal region with 1×105 AH109A cells suspended in
PBS(−) (0.5mL/rat) to produce a solid tumor, as described
previously [5] .T h es i z eo fe a c hs o l i dt u m o rw a sm e a s u r e d
every day. The tumor size is expressed as the sum of three
measured dimensions, that is, height, length, and width. On
day 20, the rats were deprived of their diets at 9:00 but
allowedfreeaccesstowateruntiltheyweresacriﬁcedat13:00.
Solid tumors were dissected and weighed. Metastatic tumor
foci in lung and inguinal and axillary lymphatic nodes were
macroscopically examined and excised, and the number of
metastatic foci was recorded.
2.9. Statistical Analysis. Data were expressed as means ±
SEM. Multiple comparison was performed by one-way anal-
ysis of variance (ANOVA) followed by Tukey-Kramer mul-
tiple comparisons test, and P<0.05 was considered statis-
tically signiﬁcant.
3. Results
3.1. Eﬀect of Piceatannol on the Proliferation of Hepatoma
C e l l sI nV i t r oa n dE xV i v o .When added to medium,
piceatannol dose-dependently and signiﬁcantly reduced the
proliferation of AH109A hepatoma cells. It commenced to
decrease at 12.5μM and continued to decrease up to 200μM
(Figure 1(A(a))). Of sera obtained from rats 1, 2, 3, and 6
hours after oral administration of piceatannol at a dose of
10 mg/kg body weight, serum obtained 2 hours after admin-
istration was found to show most prominent inhibitory
eﬀect against both the proliferation and invasion of AH109A
hepatoma cells (data not shown). Thus, we prepared sera
obtained from rats 2 hours after oral administration of
piceatannol at doses 0, 2.5, 5, and 10mg/kg body weight.
These sera also reduced dose-dependently and signiﬁcantly
the proliferation of AH109A cells as seen in Figure 1(A(b)).
3.2. Eﬀect of Piceatannol on the Cell Cycle in Hepatoma Cells.
When added to medium, piceatannol was demonstrated
to induce cell cycle arrest at G2/M phase in AH109A
cells at lower concentrations of 25 and 50μM (Figures
1(B(b)) and 1(B(c))) as compared with the control (0μM)
(Figure 1(B(a))).
3.3. Eﬀect of Piceatannol on the Apoptosis Induction in He-
patoma Cells. In contrast to the eﬀect on cell cycle, piceatan-
nol failed to induce apoptosis at lower concentration of
50μM as compared with the control (Figures 1(C(a)) and
1(C(b))). However, it induced strong apoptosis at higher
concentration of 100μM( Figure 1(C(c))).
3.4. Eﬀect of Piceatannol on the Invasion of Hepatoma
C e l l sI nV i t r oa n dE xV i v o .When added to medium,
piceatannol dose-dependently and signiﬁcantly reduced the
invasion of AH109A hepatoma cells. It commenced to
decrease at 12.5μM and continued to decrease up to 200μM
(Figure 2(A(a))). Sera obtained from rats 2 hours after oral
administrationofpiceatannolatdoses0,2.5,5,and10mg/kg
body weight also reduced dose-dependently and signiﬁcantly
the invasion of AH109A cells as shown in Figure 2(A(b)).
3.5. Eﬀect of Piceatannol on the Invasion of AH109A Cells Pre-
treated with Hydrogen Peroxide. To examine whether or not
piceatannol would inhibit the invasion of tumor cells by its
antioxidative activity, the invasion assay was performed with
AH109A cells precultured in hydrogen peroxide- (ROS-)
containing medium for 4 hours. As shown in Figure 2(B(a)),
the invasive activity of AH109A cells precultured in ROS
(25μMhydrogenperoxide)wassigniﬁcantlyhigherthanthat
of AH109A cells with no treatment. Piceatannol suppressed
the ROS-potentiated invasive activity of the precultured
cells when added to the medium at a concentration of
10μM on preculturing the hepatoma cells with ROS. In our
preliminary experiment, 12.5μM of piceatannol exposure
for 4 hours to AH109A cells exerted no inﬂuence on the
following AH109A proliferation during 24 hours (data not
shown). Thus, the concentration of 10μM of piceatannol
was adopted in this experiment to avoid an inﬂuence of
the piceatannol-mediated proliferation inhibition on the
AH109A invasion.
3.6. Intracellular Peroxide Levels of AH109A Cells Pretreated
with Hydrogen Peroxide. As illustrated in Figure 2(B(b)),
AH109A cells treated with 100μMh y d r o g e np e r o x i d ef o r
4 hours contained more intracellular peroxides than did
control cells when analyzed with a ﬂow cytometer using
DCFH-DA as an indicator (control versus H2O2). Piceatan-
nol (10μM) suppressed the rise in the intracellular peroxide
levels of AH109A cells (H2O2 versus H2O2 and piceatannol).
3.7.EﬀectofPiceatannolonSoldTumorGrowthandMetastasis
in Hepatoma-Bearing Rats. Dietary piceatannol (0.001%
and 0.005%) tended to suppress the AH109A tumor size
dose-dependently, although signiﬁcant diﬀerences were not
seen (Figure 3(A)). Accordingly, at the end of the 20-day
treatment period, the weights of solid tumors were lower
in the piceatannol-treated groups than in the control group
(Figure 3(B)). The solid tumor weight of the 0.005% pi-
ceatannol group was signiﬁcantly reduced from 20.5 ±
4.4 (control) to 9.4 ± 2.5 (0.005% piceatannol group)
g/rat, indicating that ca. 54% reduction was attained by
0.005% piceatannol. Numbers of metastatic foci were 0.22,
0.2, and 0 (number/rat) in the control, 0.001%, and 0.005%
piceatannol groups, respectively.
4. Discussion
Inthepresentstudy,piceatannolwasdemonstratedtoinhibit
both the proliferation and invasion of AH109A hepatoma
cells in vitro. Sera obtained from Donryu rats orally given
piceatannol also inhibited both the proliferation and inva-
sion of AH109A hepatoma cells ex vivo. In our previous4 Journal of Biomedicine and Biotechnology
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Figure 1: Eﬀect of piceatannol on the proliferation (A), cell cycle (B), and apoptosis of AH109A hepatoma cells (C). (A) Piceatannol was
dissolved in ethanol. The piceatannol solution was added to the culture medium at a ﬁnal ethanol concentration of 0.2%. Piceatannol
was suspended in a 0.3% carboxymethyl cellulose sodium salt (CMC) aqueous solution at concentrations of 0.25, 0.5, and 1mg/mL.
Piceatannol suspension or 0.3% CMC alone (vehicle control) (1mL/100g body weight) was intubated to male Donryu rats which had been
fasted overnight, and blood was collected 2h after oral administration. The proliferative activity was determined by [methyl-3H]thymidine
incorporation method in vitro (A(a)) and ex vivo (A(b)). Each value represents the mean ± SEM of six wells. Values not sharing a common
letter are signiﬁcantly diﬀerent at P<0.05. (B) For cell cycle analysis, 3.0 × 105 cells of AH109A per well were seeded in the medium
containing 0, 25, and 50μM piceatannol and cultured for 24h. Cells were then collected and washed twice with PBS(−). Thereafter,
propidium iodide (PI) solution was added and cells were incubated for 30 min on ice. Cells at diﬀerent cell cycle phases were then analyzed
with a ﬂow cytometer. Data are from representative experiment repeated three times with similar results (B(a)–(c)). (C) The eﬀect of
piceatannol on apoptosis in AH109A cells was assessed using Annexin V-FITC kit according to the manufacturer’s instructions. Brieﬂy,
5 × 105 cells of AH109A per well were seeded in a 6-well plate and cultured in the medium containing 0, 50, and 100 μM piceatannol for 3h.
At the end of culture, cells were labeled with Annexin-V-FITC and analyzed with a ﬂow cytometer. Data are from representative experiment
repeated three times with similar results (C(a)–(c)).Journal of Biomedicine and Biotechnology 5
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Figure 2: Eﬀect of piceatannol on the invasion of AH109A hepatoma cells (A), reactive oxygen species- (ROS-) potentiated invasive activity
and intracellular peroxide levels (B). (A) Piceatannol was dissolved in ethanol. The piceatannol solution was added to the culture medium at
a ﬁnal ethanol concentration of 0.2%. Piceatannol was suspended in a 0.3% carboxymethyl cellulose sodium salt (CMC) aqueous solution
at concentrations of 0.25, 0.5, and 1mg/mL. Piceatannol suspension or 0.3% CMC alone (vehicle control) (1mL/100g body weight) was
intubated to male Donryu rats which had been fasted overnight, and blood was collected 2h after oral administration. The invasive activity
was determined by AH109A-M cell coculture method in vitro (A(a)) and ex vivo (A(b)). Each value represents the mean ± SEM of ten
areas. Values not sharing a common letter are signiﬁcantly diﬀerent at P<0.05. (B) AH109A cells were cultured for 4h in the absence or
presence of 10 μM piceatannol with or without 25μM hydrogen peroxide (H2O2). AH109A cells were then washed once with 10% CS/MEM
and seeded on the M-cell monolayer in 10% CS/MEM without piceatannol and ROS. After cultured for 24h, invaded cells and colonies
underneath M-cells were counted with a phase-contrast microscope. Each value represents the mean ± SEM of ten areas. Values not sharing
a common letter are signiﬁcantly diﬀerent at P<0.05 (B(a)). To evaluate the eﬀect of piceatannol on intracellular peroxide levels, AH109A
cells were treated with 100μMH 2O2 as ROS source. After ROS treatment for 1 hour, DCFH-DA was added, incubated for 20 minutes, and
analyzed with a ﬂow cytometer. Basal and ROS-potentiated intracellular peroxide levels are indicated as solid and dotted lines, respectively.
Data are from representative experiment repeated three times with similar results (B(b)).6 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀect of piceatannol on tumor size (A) and weight (B) of solid tumors in hepatoma-bearing rats. (A) Tumor size was determined
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experiment, the sera obtained from Donryu rats orally given
resveratrol completely lost the antiproliferative activity ex
vivo, although its anti-invasive activity was preserved [8, 9].
These previous and present ﬁndings suggest that metabolism
of resveratrol by intestinal ﬂora, intestine itself, or in the liver
may be diﬀerent from that of piceatannol. Precise reasons for
the diﬀerence between two stilbenoids, however, are unclear
at present.
To elucidate the mechanisms for the inhibition of hep-
atomacellproliferationbypiceatannol,theeﬀectofpiceatan-
nol treatment on cell cycle and on the rate of apoptosis was
examined by using ﬂow cytometry. Piceatannol was found
to suppress the proliferation from lower concentrations (∼
25μM) by arresting cell cycle of AH109A cells at G2/M phase
(Figure1(B)).Furthermore,piceatannolincreasedtherateof
apoptosisathigherconcentrations(∼100μM)(Figure1(C)).
Dependencies of cell cycle arrest and apoptosis induction
on piceatannol concentrations are similar to those on [6]-
gingerol [11]. Although the doses of piceatannol which
induced apoptosis were higher than those which induced cell
cycle arrest in AH109A hepatoma cells, these results suggest
that piceatannol aﬀects both cell proliferation and cell death
which at least in part account for the inhibitory eﬀect of
piceatannol on the proliferation of AH109A cells.
Our previous studies have demonstrated that the inva-
sion of AH109A cells is accelerated by ROS [16, 17]. In
the present study, we therefore examined the eﬀect of
piceatannol on the ROS-potentiated invasive activity using
H2O2. Piceatannol was demonstrated to suppress the ROS-
induced elevation of the AH109A invasion (Figure 2(B(a))).
Piceatannolwasalsofoundtoscavengeintracellularperoxide
(Figure 2(B(b))). We have found that ROS can induce gene
expression of hepatocyte growth factor (HGF), which is
known as a cell motility factor [18], in M-cells as well as
AH109A cells [9, 16]. Thus, HGF produced by AH109A and
M-cells may potentiate the motility of AH109A cells, leading
to acceleration of the invasion of AH109A cells. If piceatan-
nol, like resveratrol [9], suppresses the production of HGF
through antioxidative activity, piceatannol may reduce the
motility of AH109A invasion, this leading to the reduction of
theAH109Ainvasion.Althoughpreliminarily,wehavemeas-
ured HGF secretion from AH109A cells by ELISA. Piceatan-
nol was found to dose-dependently suppress the HGF se-
cretion after exposure of AH109A to piceatannol for 1 hour
or 24 hours at the concentration ranges of 25–100μM( d a t a
not shown), suggesting an involvement of decreased HGF se-
cretion in anti-invasive activity of piceatannol against AH-
109A hepatoma cells.
Although not signiﬁcant, piceatannol dose-dependently
suppressedsolidtumorsizeinhepatoma-bearingrats(Figure
3(A)). However, solid tumor weights, a most simple but
reliable index for tumor growth, were signiﬁcantly reduced
by feeding the 0.005% diet (Figure 3(B)). In addition to in
vitro eﬃcacy, piceatannol is demonstrated to be eﬀective in
vivo in suppressing tumor growth. Antimetastatic eﬀect of
piceatannol was not clear in vivo in the present study, this
being probably due to weak metastatic activity in the control
group. Selection and use of highly metastatic AH109A cell
clone will clarify the in vivo antimetastatic eﬀect of picea-
tannol.
In summary, piceatannol was clearly demonstrated to
suppress both the proliferation and invasion of AH109A he-
patoma cells in vitro and ex vivo. Antiproliferative eﬀect mig-
ht be due to induction of cell cycle arrest and apoptosis in
AH109A, while anti-invasive eﬀect might be due to antioxi-
dative property of piceatannol. As was expected, piceatannolJournal of Biomedicine and Biotechnology 7
is shown to signiﬁcantly suppress the solid tumor growth in
vivo. These functions of piceatannol may be of signiﬁcance
from the aspects of both nutritional and pharmacological
control of cancers.
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